Your browser doesn't support javascript.
loading
Adaptively evolved human oral actinomyces-sourced defensins show therapeutic potential.
Zhu, Shunyi; Gao, Bin; Umetsu, Yoshitaka; Peigneur, Steve; Li, Ping; Ohki, Shinya; Tytgat, Jan.
Afiliação
  • Zhu S; Group of Peptide Biology and Evolution, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
  • Gao B; Group of Peptide Biology and Evolution, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
  • Umetsu Y; Center for Nano Materials and Technology (CNMT), Japan Advanced Institute of Science and Technology (JAIST), Nomi, Japan.
  • Peigneur S; Toxicology and Pharmacology, University of Leuven, Leuven, Belgium.
  • Li P; Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety (Chinese Academy of Sciences), National Center for Nanoscience and Technology, Beijing, China.
  • Ohki S; Center for Nano Materials and Technology (CNMT), Japan Advanced Institute of Science and Technology (JAIST), Nomi, Japan.
  • Tytgat J; Toxicology and Pharmacology, University of Leuven, Leuven, Belgium.
EMBO Mol Med ; 14(2): e14499, 2022 02 07.
Article em En | MEDLINE | ID: mdl-34927385
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Defensinas / Anti-Infecciosos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: EMBO Mol Med Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Defensinas / Anti-Infecciosos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: EMBO Mol Med Ano de publicação: 2022 Tipo de documento: Article